Decoding the network of Trypanosoma brucei proteins that determines sensitivity to apolipoprotein-L1

Currier, R. B., Cooper, A., Burrell-Saward, H., MacLeod, A. and Alsford, S. (2018) Decoding the network of Trypanosoma brucei proteins that determines sensitivity to apolipoprotein-L1. PLoS Pathogens, 14(1), e1006855. (doi: 10.1371/journal.ppat.1006855) (PMID:29346416) (PMCID:PMC5790291)

[img]
Preview
Text
156592.pdf - Published Version
Available under License Creative Commons Attribution.

3MB

Abstract

In contrast to Trypanosoma brucei gambiense and T. b. rhodesiense (the causative agents of human African trypanosomiasis), T. b. brucei is lysed by apolipoprotein-L1 (apoL1)-con- taining human serum trypanolytic factors (TLF), rendering it non-infectious to humans. While the mechanisms of TLF1 uptake, apoL1 membrane integration, and T. b. gambiense and T. b. rhodesiense apoL1-resistance have been extensively characterised, our under- standing of the range of factors that drive apoL1 action in T. b. brucei is limited. Selecting our bloodstream-form T. b. brucei RNAi library with recombinant apoL1 identified an array of factors that supports the trypanocidal action of apoL1, including six putative ubiquitin modifiers and several proteins putatively involved in membrane trafficking; we also identified the known apoL1 sensitivity determinants, TbKIFC1 and the V-ATPase. Most prominent amongst the novel apoL1 sensitivity determinants was a putative ubiquitin ligase. Intrigu- ingly, while loss of this ubiquitin ligase reduces parasite sensitivity to apoL1, its loss en- hances parasite sensitivity to TLF1-dominated normal human serum, indicating that free and TLF1-bound apoL1 have contrasting modes-of-action. Indeed, loss of the known human serum sensitivity determinants, p67 (lysosomal associated membrane protein) and the cathepsin-L regulator, ‘inhibitor of cysteine peptidase’, had no effect on sensitivity to free apoL1. Our findings highlight a complex network of proteins that influences apoL1 action, with implications for our understanding of the anti-trypanosomal action of human serum.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:MacLeod, Professor Annette and Cooper, Dr Anneli
Creator Roles:
Cooper, A.Resources, Writing – review and editing
MacLeod, A.Funding acquisition, Resources, Writing – review and editing
Authors: Currier, R. B., Cooper, A., Burrell-Saward, H., MacLeod, A., and Alsford, S.
College/School:College of Medical Veterinary and Life Sciences > Institute of Biodiversity Animal Health and Comparative Medicine
Journal Name:PLoS Pathogens
Publisher:Public Library of Science
ISSN:1553-7366
ISSN (Online):1553-7374
Copyright Holders:Copyright © 2018 Currier et al.
First Published:First published in PLoS Pathogens 14(1): e1006815
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
558211The origins and mechanisms of human infectivity in African trypanosomes.Annette MacLeodWellcome Trust (WELLCOTR)095201/Z/10/ZRI BIODIVERSITY ANIMAL HEALTH & COMPMED